Pharmamar’s Stock Soars: Is a Game-Changer on the Horizon?
Pharmamar’s stock has increased over 12% recently, reaching 83 euros. The company is nearing a significant resistance point, having struggled to break it since October. Strong financial outcomes in the U.S. pharma sector have made it attractive to investors. Experts suggest that